Psychosis prediction and prevention is a clinical research priority. But recent research has shown that <10% of psychotic disorders are identified using current "high risk" approaches - the Clinical High Risk and Familial High Risk approaches.
This session will describe the state of the art on psychosis prediction and prevention research internationally. It will showcase new findings on the early identification of psychosis risk in mental health services (with a focus on child and adolescent mental health services). It will explain how different approaches within mental health services can capture risk for future psychosis. And it will present cutting edge research on how early-life treatments for common mental health problems (depression, anxiety, ADHD) impact on subsequent psychosis risk.
Learning objectives
By attending this session you will gain:
- Understanding on current approaches to identifying psychosis risk
- Understanding of the strengths and limitations of symptom-based assessments (such as Clinical High Risk assessments) in identifying risk for psychosis
- Understanding of how risk for psychosis is routinely captured in child and adolescent mental health services
- Understanding of how treatment of common mental health conditions in childhood impacts on subsequent psychosis risk.
Speakers
Chair: Professor Ian Kelleher, University of Edinburgh, Edinburgh
Professor Ian Kelleher, University of Edinburgh, Edinburgh
Dr Kirstie O'Hare, University of Edinburgh, Edinburgh
Dr Valentina Kieseppä, University of Oulu, Oulu, Finland
Dr Colm Healy, University College Dublin, Dublin
Availability
This webinar is part of the Congress webinar 2025 package. If you attended all four days of Congress, you will have access to these as part of your Congress package. Otherwise the Congress webinar 2025 package can be purchased below.
